EFFICACY AND SAFETY OF LENVATINIB COMBINED WITH DIFFERENT ANTI-PD-1 ANTIBODY IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: A REAL WORLD EVIDENCE BASED RETROSPECTIVE STUDY

被引：0
|
作者：
Chen, Bowen [1 ]
Zhang, Linzhi [2 ,3 ]
Cheng, Jiamin, Sr. [2 ]
Yan, Tao [2 ]
Lu, Yinying [1 ]
机构：
[1] Peking Univ, Clin Med Sch 302, Beijing, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Beijing, Peoples R China
[3] Tianjin Med Univ Canc Inst & Hosp, Tianjin, Peoples R China
来源：
HEPATOLOGY | 2021年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1045
引用
收藏
页码：637A / 638A
页数：2
相关论文
共 50 条
  • [41] Outcomes of Patients with Advanced Hepatocellular Carcinoma Receiving Lenvatinib following Immunotherapy: A Real World Evidence Study
    Palmer, Mathias E.
    Gile, Jennifer J.
    Storandt, Michael H.
    Jin, Zhaohui
    Zemla, Tyler J.
    Tran, Nguyen H.
    Mahipal, Amit
    CANCERS, 2023, 15 (19)
  • [42] Enhanced efficacy of combined VEGFR peptide–drug conjugate and anti-PD-1 antibody in treating hepatocellular carcinoma
    Jiacheng Liu
    Yaowei Bai
    Xiaoming Liu
    Binqian Zhou
    Peng Sun
    Yingliang Wang
    Shuguang Ju
    Chen Zhou
    Chaoyang Wang
    Wei Yao
    Huihui Yang
    Xin Jiang
    Lian Yang
    Dongyuan Wang
    Chuansheng Zheng
    Scientific Reports, 14 (1)
  • [43] The efficacy and safety of donafenib combined with transcatheter arterial chemoembolization and anti-PD-1 antibodies as first-line therapy for hepatocellular carcinoma: A retrospective study
    Song, Danjun
    Hao, Weiyuan
    Cao, Fei
    Luo, Jun
    Guo, Liwen
    Zhang, Zhewei
    Zheng, Jiaping
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [44] Effects of combination therapy using lenvatinib and anti-pd-1 antibody on liver function in patients with advanced hepatocellar carcinoma
    Shen, Y.
    Sun, H.
    Huang, C.
    Zhu, X.
    Xu, M.
    Tan, C.
    Liang, F.
    Zhou, J.
    Fan, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S691 - S691
  • [45] Real-world study of hepatic artery infusion chemotherapy combined with anti-PD-1 immunotherapy and tyrosine kinase inhibitors for advanced hepatocellular carcinoma
    Liu, Bao-Jiang
    Gao, Song
    Zhu, Xu
    Guo, Jian-Hai
    Kou, Fu-Xin
    Liu, Shao-Xing
    Zhang, Xin
    Wang, Xiao-Dong
    Cao, Guang
    Chen, Hui
    Liu, Peng
    Xu, Hai-Feng
    Gao, Qin-Zong
    Yang, Ren-Jie
    IMMUNOTHERAPY, 2021, 13 (17) : 1395 - 1405
  • [46] Hepatic arterial infusion chemotherapy combined with anti-PD-1/PD-L1 immunotherapy and molecularly targeted agents for advanced hepatocellular carcinoma: a real world study
    Zhang, Weihao
    Zhang, Kai
    Liu, Changfu
    Gao, Wei
    Si, Tongguo
    Zou, Qiang
    Guo, Zhi
    Yang, Xueling
    Li, Mei
    Liu, Dongming
    Mu, Han
    Li, Huikai
    Yu, Haipeng
    Xing, Wenge
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [47] A prospective study exploring the safety and efficacy of lenvatinib for patients with advanced hepatocellular carcinoma potential in current real-world practice.
    Kobayashi, Kazufumi
    Ogasawara, Sadahisa
    Maruta, Susumu
    Okubo, Tomomi
    Moriguchi, Michihisa
    Kanzaki, Hiroaki
    Koroki, Keisuke
    Kanogawa, Naoya
    Shiko, Yuki
    Inaba, Yosuke
    Nakamura, Kazuyoshi
    Azemoto, Ryosaku
    Ito, Kenji
    Okabe, Shinichiro
    Atsukawa, Masanori
    Itobayashi, Ei
    Ikeda, Masafumi
    Morimoto, Naoki
    Itoh, Yoshito
    Kato, Naoya
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 512 - 512
  • [48] Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real-world setting
    Sho, Takuya
    Suda, Goki
    Ogawa, Koji
    Kimura, Megumi
    Shimazaki, Tomoe
    Maehara, Osamu
    Shigesawa, Taku
    Suzuki, Kazuharu
    Nakamura, Akihisa
    Ohara, Masatsugu
    Umemura, Machiko
    Kawagishi, Naoki
    Natsuizaka, Mitsuteru
    Nakai, Masato
    Morikawa, Kenichi
    Furuya, Ken
    Baba, Masaru
    Yamamoto, Yoshiya
    Kobayashi, Tomoe
    Meguro, Takashi
    Saga, Akiyoshi
    Miyagishima, Takuto
    Yokoo, Hideki
    Kamiyama, Toshiya
    Taketomi, Akinobu
    Sakamoto, Naoya
    JGH OPEN, 2020, 4 (01): : 54 - 60
  • [49] The efficacy and safety of Radiofrequency ablation combined with Lenvatinib plus Sintilimab in Unresectable Hepatocellular Carcinoma: a real-world study
    Wang, Xishu
    Sun, Ximin
    Lei, Yongrong
    Fang, Lingyan
    Wang, Yuedi
    Feng, Kai
    Xia, Feng
    BMC CANCER, 2024, 24 (01)
  • [50] Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real-world setting
    Sho, Takuya
    Suda, Goki
    Ogawa, Koji
    Nakai, Masato
    Morikawa, Kenichi
    Sakamoto, Naoya
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E621 - E621
12345